ODC1 and neuroblastoma: The results from this study suggest that genetic variability affecting ODC expression, specifically the rs2302616 SNP, is associated with increased polyamines, enhanced susceptibility to the ODC inhibitor DFMO and subsequent increased responsiveness to DFMO containing therapies in patients with NB.